Priest, Elisa
Baylor Scott & White Research Institute
6 papers on CoChatORCID 0000-0003-0474-6275
Most cited papers
- Verified
Exercise capacity and body composition as predictors of mortality among men with diabetes
Church, T. S., Cheng, Y. J., Earnest, C. P., Barlow, C. E., Gibbons, L. W., Priest, E. L., & Blair, S. N. (2004) · Diabetes Care
Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 469
- Verified
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021
Self, W. H., Tenforde, M. W., Rhoads, J. P., Gaglani, M., Ginde, A. A., Douin, D. J., Olson, S. M., Talbot, H. K., Casey, J. D., Mohr, N. M., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report
SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy
Cited by 406
- Verified
Association of Cardiorespiratory Fitness, Body Mass Index, and Waist Circumference to Nonalcoholic Fatty Liver Disease
Church, T. S., Kuk, J. L., Ross, R., Priest, E. L., Biltoff, E., & Blair, S. N. (2006) · Gastroenterology
Liver Disease Diagnosis and TreatmentPhysical Activity and Health
Cited by 268
- Verified
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021
Tenforde, M. W., Self, W. H., Naioti, E. A., Ginde, A. A., Douin, D. J., Olson, S. M., Talbot, H. K., Casey, J. D., Mohr, N. M., Zepeski, A., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report
SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy
Cited by 204
- Verified
Obesity, macrophage migration inhibitory factor, and weight loss
Church, T. S., Willis, M. S., Priest, E. L., LaMonte, M. J., Earnest, C. P., Wilkinson, W. J., Wilson, D. A., & Giroir, B. P. (2005) · International Journal of Obesity
Macrophage Migration Inhibitory FactorAdipokines, Inflammation, and Metabolic Diseases
Cited by 60
- Verified
Cardiovascular events in individuals treated with sulfonylureas or dipeptidyl peptidase 4 inhibitors
Turchin, A., Petito, L. C., Hegermiller, E., Carnahan, R., DeVries, A., Goel, S., Lansang, M. C., McDonnell, M. E., Nair, V., Priest, E., et al. (2025) · JAMA Network Open
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 14
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free